Drug Type Small molecule drug |
Synonyms OS300 |
Target |
Action agonists |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingNDA/BLA |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | NDA/BLA | - | - | |
| Meibomian Gland Dysfunction | Preclinical | United States | 01 Jul 2019 |





